U.S. Building Stock News

Alamar Biosciences (NasdaqGS:ALMR) doubled its revenue in Q1 2026. The company launched two new products aimed at neurodegenerative disease research. Alamar completed an IPO in 2026 to support its next phase of growth. Alamar Biosciences operates in the life sciences tools and diagnostics space, where demand for more precise protein and biomarker measurement has been a key theme for researchers and drug developers. The new products focused on neurodegenerative disease research sit in an...

Why the upcoming TN-401 data matters for Tenaya Therapeutics stock Tenaya Therapeutics (TNYA) is drawing attention as investors look ahead to new clinical safety and efficacy data for TN-401, its gene therapy for PKP2-associated arrhythmogenic right ventricular cardiomyopathy, at the ASGCT 2026 meeting. This late breaking oral presentation, together with additional abstracts on Tenaya’s gene therapy and gene editing programs, gives you fresh information to evaluate the company’s pipeline...

Brixmor Property Group Inc. recently reported first-quarter 2026 results showing year-on-year growth in revenue to US$354.82 million and net income to US$127.75 million, while also updating full-year guidance to net income of US$355 million to US$365 million and diluted EPS of US$1.16 to US$1.19. Alongside the earnings update, the board affirmed a quarterly dividend of US$0.3075 per share and highlighted that 2026 uncollectible revenues are expected to remain contained at 75 to 100 basis...

In early May 2026, Rackspace Technology reported first-quarter 2026 revenue of US$678.1 million and net income of US$8.3 million, marking a move back into profit from a net loss a year earlier. On the same day, Rackspace Technology and AMD announced a Memorandum of Understanding for a multiyear partnership to build a governed Enterprise AI Cloud tailored to regulated and sovereign workloads, expanding Rackspace’s role in managed AI infrastructure. Next, we’ll examine how Rackspace’s new...

Sarepta Therapeutics (NasdaqGS:SRPT) is progressing its small interfering RNA (siRNA) candidates SRP-1001 and SRP-1003, with early data viewed as encouraging. The company is seeking to transition AMONDYS 45 and VYONDYS from accelerated to traditional FDA approvals through recent regulatory submissions. These updates come as Sarepta refines its commercial focus beyond gene therapy Elevidys, which continues to face regulatory and commercial complexity. Sarepta Therapeutics focuses on rare...

Why Gold.com (GOLD) is back on investors’ radar after record Q3 results Gold.com (GOLD) is in focus after reporting record fiscal third quarter revenue of US$10.35b, a swing to net income of US$59.49m, and affirming a quarterly dividend alongside new digital asset partnerships. See our latest analysis for Gold.com. At a share price of US$43.51, Gold.com has seen a 25.14% year to date share price return and a very large 1 year total shareholder return of 114.36%. However, the 90 day share...

Star Holdings (STHO) closed out FY 2025 with Q4 revenue of US$33.4 million and a basic EPS loss of US$1.51, alongside a net loss of US$19.1 million, with trailing twelve month revenue at US$118.1 million and a TTM basic EPS loss of US$4.90. Over the past six quarters in the data, quarterly revenue has ranged from US$14.6 million to US$42.1 million while basic EPS has swung between a profit of US$6.90 and a loss of US$7.70. This sets the backdrop for a stock priced at US$8.84 today. For...

Wendy's (NasdaqGS:WEN) has announced a major franchise agreement to open up to 1,000 restaurants in China over the next decade. The expansion is part of its "Project Fresh" turnaround plan and is intended to offset weaker U.S. same-restaurant sales. The deal marks a shift in focus toward international markets as the company looks for new long term growth drivers. Wendy's, trading at around $6.95, has seen extended share price pressure, with the stock down 14.9% year to date and 39.1% over...

If you are wondering whether Chevron at around US$182.50 is offering fair value or if you are paying up for the story, this article walks through what the numbers are actually saying about the stock. The share price has pulled back recently, with a 5.6% decline over the last 7 days and a 9.4% decline over the last 30 days, while still showing returns of 17.1% year to date and 39.2% over 1 year. Recent headlines around Chevron have focused on broad energy sector sentiment and ongoing interest...

Natera (NasdaqGS:NTRA) raised its full-year 2026 revenue and gross margin guidance after reporting record test volumes. The company cited accelerating growth in both women's health and oncology segments as key drivers. Natera also outlined plans to commercially launch its Signatera MRD test in Japan, aiming to extend its international reach. Natera enters this update with its stock at $219.82 and a 1 year return of 35.2%, and a 3 year return that is a very large multiple of its earlier...

CoStar Group (NasdaqGS:CSGP) is set to be removed from the Nasdaq-100 Index. The change affects the stock's role in one of the most followed US equity benchmarks. Index adjustments can influence passive fund holdings and trading activity in the shares. For investors watching CoStar Group, the index removal intersects with a share price that most recently closed at $34.98. The stock has recorded a 1.1% return over the past week, alongside longer term declines of 11.4% over 30 days, 46.7%...

Wondering if AMETEK at around US$234.73 is offering fair value or if you might be paying up for quality? This article breaks down what the current price could mean for you. The stock has been relatively flat over the last 7 days with a 0.3% decline, but sits on gains of 7.8% over 30 days, 12.2% year to date and 37.7% over 1 year. This naturally raises questions about how much of the story is already priced in. Recent coverage has focused on AMETEK's position in the capital goods space and...

Kulicke and Soffa Industries (KLIC) has drawn fresh attention after a strong recent run in its stock, with returns over the past month and the past 3 months sharply outpacing its longer term performance. See our latest analysis for Kulicke and Soffa Industries. The recent move takes the share price to $98.15, with a 30-day share price return of 46.10% and a year-to-date share price return of 103.00%, while the 1-year total shareholder return of 215.22% highlights that momentum has been...

Why Brown & Brown (BRO) is Back on Investors’ Radar Brown & Brown (BRO) has drawn fresh attention after recent trading left the stock about 25% lower year to date, with the share price at US$58.05 and a market value near US$19.2b. See our latest analysis for Brown & Brown. The 1-day share price return of 2.63% sits against a 30-day share price return of 12.54% and a year to date share price return of 25.21%. The 1-year total shareholder return of 47.57% contrasts with a 3-year total...

This article examines whether Energizer Holdings, at US$18.56, could be a bargain or a value trap, and explains what the current share price might be implying. The stock has recently seen mixed returns, with an 11.1% gain over the last 30 days but declines of 5.2% over 7 days, 6.9% year to date, and 11.5% over 1 year, extending to 39.8% over 3 years and 52.2% over 5 years. Recent coverage has focused on how Energizer Holdings fits into the broader household products sector, as investors...

DorianG (LPG) has been drawing attention after recent share price strength. The stock’s value score of 3 and an intrinsic discount of 38.4% are prompting closer scrutiny from income and value focused investors. See our latest analysis for DorianG. The recent 16.78% 1-month share price return and 23.06% 3-month share price return suggest momentum is building, set against a 99% 1-year total shareholder return and the current $39.81 share price relative to its assessed discount. If this kind of...

AdvanSix (ASIX) closed out FY 2025 with Q4 revenue of US$359.9 million and a basic EPS loss of US$0.10. The trailing twelve months show EPS of US$1.83 on revenue of about US$1.5 billion. Over recent periods, revenue has moved from US$329.1 million in Q4 2024 to US$410.0 million in Q2 2025. Quarterly EPS has ranged from a small profit of US$0.01 in Q4 2024 to a high of US$1.17 in Q2 2025, giving investors a mix of profitable quarters and losses at the year end. With net profit margin at 3.2%...

At its early May 2026 Knowledge conference, ServiceNow rolled out a suite of enterprise AI offerings, including the Otto assistant, expanded AI Control Tower, and Project Arc with NVIDIA, alongside deeper collaborations with partners such as Microsoft, Lenovo, FedEx, and NiCE. Taken together, these launches and alliances push ServiceNow further toward being an AI governance and workflow hub that other agents, devices, and data platforms plug into rather than a standalone software...

Energy Transfer (NYSE:ET) reported robust first quarter results and updated full year EBITDA guidance. The company increased its capital expenditure outlook for 2024 to support new growth projects. Key projects are progressing in the Permian Basin and in energy infrastructure tied to data centers. Management highlighted record transport volumes and a focus on pipeline expansion and exports. Energy Transfer is one of the largest midstream companies in North America, with assets that move and...

In early May 2026, Automatic Data Processing, Inc. completed a US$1.0 billion offering of 5.000% senior unsecured notes due 2036, alongside reporting third-quarter fiscal 2026 results that showed higher sales, revenue, net income and earnings per share compared with the same period a year earlier. Together with ADP’s April National Employment Report showing the fastest private-sector job growth in over a year, the successful debt raise highlights how the company’s operating strength and...

In early May 2026, Wall Street analysts projected that American Public Education’s quarterly earnings per share would rise by very large year-over-year and revenue would increase by 5.6%, supported by improved student enrollment and net course registrations at Rasmussen University and Hondros College. These forecasts, alongside American Public University System’s recent commencement celebrating more than 17,700 graduates, highlight growing operational momentum across the company’s core...

Recent performance snapshot Penumbra (PEN) has drawn investor attention after recent trading, with the stock last closing at US$324.65. Short term moves have been mixed, with a small 1 day gain alongside a slight 7 day decline. See our latest analysis for Penumbra. Looking past the latest move, Penumbra’s recent share price return has been softer, with a 90 day decline of 4.8%. However, the year to date share price return of 4.92% sits alongside a 12.44% total shareholder return over the last...

John Wiley & Sons (WLY) has reshaped its leadership in Research by appointing Jessica Kowalski as Executive Vice President and General Manager, following the departure of Jay Flynn, who helped shape the segment’s direction. See our latest analysis for John Wiley & Sons. The leadership moves around AI and research publishing come as WLY’s share price sits at US$40.70, with a 30 day share price return of 6.38% and a 90 day share price return of 39.19%, while the 1 year total shareholder return...

Executive hire signals shift toward commercial execution Enovix (ENVX) has drawn fresh attention after appointing Steve Bakos as Senior Vice President of Worldwide Sales, a new role that aligns with its push toward commercializing 100% silicon-anode batteries. Bakos, who brings more than 35 years of global semiconductor sales experience and prior leadership at Infineon Technologies and several other chip companies, is joining as Enovix ramps its silicon-enhanced product line from Korea and...